Brazil, the largest healthcare market in Latin America, is a crucial player in the region’s health industry as it commands 9.47% of its GDP towards healthcare expenditures. This is equivalent to $161 billion. This considerable investment stresses on the importance of healthcare in Brazil’s economy and reflects the country’s efforts to meet the needs of its diverse and aging population. Brazil’s healthcare system is a dual model, comprising both public and private sectors. The Unified Healthcare System (SUS), which is government-funded, serves as the primary healthcare provider for approximately 72% of Brazil’s population. SUS is renowned for offering a wide range of services, from medical diagnostics and treatment to national vaccination programs, especially for children and the elderly. The system has also been instrumental in the country’s COVID-19 vaccination campaign. In addition to the public system, the private healthcare sector is substantial, with 62% of the country’s 7,191 hospitals operating privately. This sector caters to around 50.7 million Brazilians, offering more personalized and often faster healthcare services compared to the public system. The presence of 710 health insurance providers indicates a robust demand for private healthcare services, driven by the desire for more comprehensive coverage and access to a wider range of treatments. The health industry in Brazil is tightly regulated by the National Health Surveillance Agency (ANVISA), which ensures that all health-related products meet stringent standards. This regulatory framework is vital for maintaining the quality and safety of healthcare products and services in the country. However, navigating this regulatory landscape can be challenging for foreign companies, as compliance with sanitary registration requirements is mandatory, particularly when selling to the government. The Brazilian healthcare market is predominantly price-driven, which makes locally manufactured products more competitive due to their lower cost structure. For foreign companies, this price sensitivity necessitates the adoption of cost-saving measures.